Trial Profile
Response to Ipilimumab in Melanoma Patients with Brain Metastases: A Retrospective Review
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2017
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Brain metastases; Malignant melanoma
- Focus Therapeutic Use
- 08 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology